148 related articles for article (PubMed ID: 26792691)
1. [Relationship between interleukin-8 levels in expressed prostatic secretion and expressions of bFGF and Bcl-2 in benign prostatic hyperplasia].
Song W; Li DY; Yuan HC; Gu ZH; Shao JL; Wang X
Zhonghua Yi Xue Za Zhi; 2016 Jan; 96(2):104-7. PubMed ID: 26792691
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of interleukin-8 in expressed prostatic secretion as a reliable biomarker of inflammation in benign prostatic hyperplasia.
Liu L; Li Q; Han P; Li X; Zeng H; Zhu Y; Wei Q
Urology; 2009 Aug; 74(2):340-4. PubMed ID: 19464042
[TBL] [Abstract][Full Text] [Related]
3. [Correlation of IPSS with IL-8 and COX-2 levels in patients with benign prostatic hyperplasia and prostatitis].
Chen DA; Yang XZ; Zhang PH; Li GS; Chang DG
Zhonghua Nan Ke Xue; 2013 Jun; 19(6):527-30. PubMed ID: 23862231
[TBL] [Abstract][Full Text] [Related]
4. [Expressions of SIgA and alpha 1-AR in benign prostatic hyperplasia combined with chronic prostatitis and their implications].
Gao WJ; Wang YM; Wang CH; Yang XK; Wan L; Li WP
Zhonghua Nan Ke Xue; 2013 Apr; 19(4):315-20. PubMed ID: 23678709
[TBL] [Abstract][Full Text] [Related]
5. Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia.
Penna G; Mondaini N; Amuchastegui S; Degli Innocenti S; Carini M; Giubilei G; Fibbi B; Colli E; Maggi M; Adorini L
Eur Urol; 2007 Feb; 51(2):524-33; discussion 533. PubMed ID: 16905241
[TBL] [Abstract][Full Text] [Related]
6. [Expressions of interleukin-17 and interleukin-8 in the prostatic tissue of the patients with BPH or BPH with inflammation].
Gao R; Liu QX; Zhou HL; Cao LS; Jiang T; Tang SX; Ding YL
Zhonghua Nan Ke Xue; 2017 Aug; 23(8):697-702. PubMed ID: 29726643
[TBL] [Abstract][Full Text] [Related]
7. Expression of basic fibroblast growth factor and its receptors FGFR1 and FGFR2 in human benign prostatic hyperplasia treated with finasteride.
Sáez C; González-Baena AC; Japón MA; Giráldez J; Segura DI; Rodríguez-Vallejo JM; González-Esteban J; Miranda G; Torrubia F
Prostate; 1999 Jul; 40(2):83-8. PubMed ID: 10386468
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of interleukin-2 receptor and interleukin-6 in patients with prostate cancer and benign prostatic hyperplasia: association with asymptomatic inflammatory prostatitis NIH category IV.
Engelhardt PF; Seklehner S; Brustmann H; Lusuardi L; Riedl CR
Scand J Urol; 2015 Apr; 49(2):120-6. PubMed ID: 25363611
[TBL] [Abstract][Full Text] [Related]
9. [The effectiveness of the integrated approach to the treatment of chronic prostatitis, including in patients with benign prostatic hyperplasia].
Zhiborev AB; Martov AG
Urologiia; 2018 Oct; (4):81-87. PubMed ID: 30761794
[TBL] [Abstract][Full Text] [Related]
10. [Expression of Ki-67, Bcl-2,Bax and caspase-3 in benign prostatic hyperplasia combined with prostatitis and their significances].
Wang L; Yang JR; Yang LY; Liu ZT; Rao JM; Liu LF
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 33(3):222-6. PubMed ID: 18382056
[TBL] [Abstract][Full Text] [Related]
11. [Correlation of IL-8 and IL-6 in prostatic fluid with serum prostate-specific antigen level in patients with benign prostatic hyperplasia complicated by prostatitis].
Ren X; Wu C; Yu Q; Zhu F; Liu P; Zhang H
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jan; 36(1):135-9. PubMed ID: 26806754
[TBL] [Abstract][Full Text] [Related]
12. [The relationship between anaphylatoxin C3a and benign prostatic hyperplasia with inflammation].
Xie L; Cheng SL; Li YZ; Liu LR; Han P; Chen N; Wei Q; Zhou Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Sep; 42(5):642-5. PubMed ID: 22007489
[TBL] [Abstract][Full Text] [Related]
13. Is there a relationship between the amount of tissue removed at transurethral resection of the prostate and clinical improvement in benign prostatic hyperplasia.
Hakenberg OW; Helke C; Manseck A; Wirth MP
Eur Urol; 2001 Apr; 39(4):412-7. PubMed ID: 11306879
[TBL] [Abstract][Full Text] [Related]
14. [Benign prostate hyperplasia with chronic prostatitis: an update].
Ma Y; Zhang WL
Zhonghua Nan Ke Xue; 2010 Jul; 16(7):646-50. PubMed ID: 20873602
[TBL] [Abstract][Full Text] [Related]
15. Microwave thermotherapy for benign prostatic hyperplasia.
Hoffman RM; Monga M; Elliot SP; Macdonald R; Wilt TJ
Cochrane Database Syst Rev; 2007 Oct; (4):CD004135. PubMed ID: 17943811
[TBL] [Abstract][Full Text] [Related]
16. Correlations of glucose metabolism, insulin resistance and inflammatory factors with symptom score of patients with benign prostatic hyperplasia.
Zhou B; Wang P; Xu WJ; Li YM; Tong DL; Jiang J; Sun ZY
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5077-5081. PubMed ID: 30178825
[TBL] [Abstract][Full Text] [Related]
17. [Clinical features of benign prostatic hyperplasia complicated by chronic prostatitis].
Chang DG; Li GS; Zhang PH; Wu TL; Mei XF; Cao J; Gao P
Zhonghua Nan Ke Xue; 2010 Sep; 16(9):830-3. PubMed ID: 21171270
[TBL] [Abstract][Full Text] [Related]
18. Distribution of chronic prostatitis in radical prostatectomy specimens with up-regulation of bcl-2 in areas of inflammation.
Gerstenbluth RE; Seftel AD; MacLennan GT; Rao RN; Corty EW; Ferguson K; Resnick MI
J Urol; 2002 May; 167(5):2267-70. PubMed ID: 11956490
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-α expression in patients with obstructive benign prostatic hyperplasia is associated with a higher incidence of asymptomatic inflammatory prostatitis NIH category IV and prostatic calcification.
Engelhardt PF; Seklehner S; Brustmann H; Riedl C; Lusuardi L
Scand J Urol; 2015 Dec; 49(6):472-478. PubMed ID: 25959105
[TBL] [Abstract][Full Text] [Related]
20. [LUTS in BPH patients with histological prostatitis before and after transurethral resection of the prostate].
Huang XH; Qin B; Liang YW; Wu QG; Li CZ; Wei GS; Ji HC; Liang YB; Chen HQ; Guan T
Zhonghua Nan Ke Xue; 2013 Jan; 19(1):35-9. PubMed ID: 23469659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
